NTRA

Natera
D

NTRA

Arincen62/100B
310.29
USD
-53.37
(-14.68%)
Post Trading·311.02USD+0.73(+0.24%)
Last updated: · Delayed 15 min
Q3 FY2026 results
EPS-0.42-49.3%Revenue793.98M+12.2%
OverviewFinancialsForecastEarningsCompany

Natera executives and insider trading

Steven Leonard Chapman sold 256,513 shares for 61.11M USD in 53 sales over the last twelve months, the last on 2 November 2026, and bought none on the open market.

Over the last twelve months Natera's insiders sold 1,373,742 shares for 347.84M USD in 520 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
520
Shares sold
1,373,742
Value sold
347.84M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
3.88M USD
0
1 month
33.71M USD
0
3 months
107.41M USD
0
6 months
173.79M USD
0
1 year
347.84M USD
0
2 years
455.38M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Steven Leonard Chapman CEOChief Executive Officer & Director47256,51361.11M USD—2 Nov 202691,211
Matthew Rabinowitz Co-Founder & Executive Chairman53517,623135.26M USD—2 Nov 20262,117,659
Jonathan Sheena Co-Founder & Director53106,76130.26M USD—2 Nov 2026217,683
Solomon Moshkevich President of Clinical Diagnostics4493,52224.87M USD—2 Nov 2026104,733
Daniel Rabinowitz Secretary & Chief Legal Officer5798,44024.05M USD—2 Nov 2026168,214
Michael Brophy Chief Financial Officer4691,48622.69M USD—3 Nov 202645,779
Roelof Botha Director—75,00017.71M USD—24 Nov 20254,585
Herm Rosenman Director—64,94915.14M USD—24 Jun 20265,927
John Fesko President & Chief Business Officer4738,0819.77M USD—2 Nov 2026195,571
Roy D. Baynes Director—12,7802.81M USD—20 Nov 202520,158
Gail Boxer Marcus Director—11,0002.39M USD—5 Jun 20267,852
Rowan E Chapman Director—7,5871.76M USD—15 Jul 20264,663

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
3 Nov 2026Michael BrophySale470391.49184.00K USD45,779Form 4
2 Nov 2026Jonathan SheenaSale3388.201.16K USD217,683Form 4
2 Nov 2026Jonathan SheenaSale109400.2943.63K USD217,574Form 4
2 Nov 2026Matthew RabinowitzSale17388.206.60K USD2,117,659Form 4
2 Nov 2026Matthew RabinowitzSale731400.29292.62K USD2,116,928Form 4
2 Nov 2026Daniel RabinowitzSale7388.202.72K USD168,214Form 4
2 Nov 2026Daniel RabinowitzSale334400.29133.70K USD167,880Form 4
2 Nov 2026Solomon MoshkevichSale9388.203.49K USD104,733Form 4
2 Nov 2026Solomon MoshkevichSale410400.29164.12K USD104,323Form 4
2 Nov 2026Solomon MoshkevichSale200405.2681.05K USD104,123Form 4
2 Nov 2026Solomon MoshkevichSale432406.94175.80K USD103,691Form 4
2 Nov 2026Solomon MoshkevichSale408408.08166.50K USD103,283Form 4
2 Nov 2026Solomon MoshkevichSale520409.46212.92K USD102,763Form 4
2 Nov 2026Solomon MoshkevichSale120410.7249.29K USD102,643Form 4
2 Nov 2026Solomon MoshkevichSale120411.7349.41K USD102,523Form 4

Common questions about Natera's executives and insiders

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.